Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Abraham Morgentaler, M.D.

Title
Institution
Department
Address
Phone
Fax

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Samoszuk M, Morgentaler A, de Groot M, van Solinge W, Li Y, Adair F, Hoefer I, Haitjema S. Association of low testosterone with changes in non-cardiovascular biomarkers in adult men. Int J Impot Res. 2019 Jan 22. PMID: 30670838.
    Citations:    Fields:    
  2. Traish A, Bolanos J, Nair S, Saad F, Morgentaler A. Do Androgens Modulate the Pathophysiological Pathways of Inflammation? Appraising the Contemporary Evidence. J Clin Med. 2018 Dec 14; 7(12). PMID: 30558178.
    Citations:    
  3. Morgentaler A. Testosterone therapy and medical hysteria. Nat Rev Urol. 2018 Nov; 15(11):659-660. PMID: 30166594.
    Citations:    Fields:    
  4. Morgentaler A. Nerve growth factor as a new treatment for testosterone deficiency? EBioMedicine. 2018 10; 36:10-11. PMID: 30249544.
    Citations:    Fields:    
  5. Morgentaler A. Current Diagnostic Criteria for Testosterone Deficiency Are Inadequate. Eur Urol Focus. 2018 04; 4(3):348-350. PMID: 30224264.
    Citations:    Fields:    
  6. Traish AM, Krakowsky Y, Doros G, Morgentaler A. Do 5a-Reductase Inhibitors Raise Circulating Serum Testosterone Levels? A Comprehensive Review and Meta-Analysis to Explaining Paradoxical Results. Sex Med Rev. 2019 01; 7(1):95-114. PMID: 30098986.
    Citations:    Fields:    
  7. Miner M, Morgentaler A, Khera M, Traish AM. The state of testosterone therapy since the FDA's 2015 labelling changes: Indications and cardiovascular risk. Clin Endocrinol (Oxf). 2018 Jul; 89(1):3-10. PMID: 29486065.
    Citations: 1     Fields:    
  8. Morgentaler A, Traish A. The History of Testosterone and the Evolution of its Therapeutic Potential. Sex Med Rev. 2018 Apr 13. PMID: 29661690.
    Citations:    Fields:    
  9. Lopez DS, Qiu X, Advani S, Tsilidis KK, Khera M, Kim J, Morgentaler A, Wang R, Canfield S. Double trouble: Co-occurrence of testosterone deficiency and body fatness associated with all-cause mortality in US men. Clin Endocrinol (Oxf). 2018 Jan; 88(1):58-65. PMID: 29067698.
    Citations:    Fields:    Translation:Humans
  10. Morgentaler A. Testosterone Therapy in a Man with Intermediate-risk Prostate Cancer: Pro. Eur Urol Focus. 2017 10; 3(4-5):316-318. PMID: 28988938.
    Citations:    Fields:    Translation:Humans
  11. Morgentaler A, Polzer P, Althof S, Bolyakov A, Donatucci C, Ni X, Patel AB, Basaria S. Delayed Ejaculation and Associated Complaints: Relationship to Ejaculation Times and Serum Testosterone Levels. J Sex Med. 2017 09; 14(9):1116-1124. PMID: 28807505.
    Citations: 1     Fields:    Translation:Humans
  12. Krakowsky Y, Conners W, Davidson E, Rawji A, Morgentaler A. Initial Clinical Experience With Testosterone Undecanoate Therapy (AVEED) in Men With Testosterone Deficiency in the United States. Urology. 2017 Nov; 109:27-31. PMID: 28735014.
    Citations:    Fields:    Translation:Humans
  13. Krakowsky Y, Morgentaler A. Risk of Testosterone Flare in the Era of the Saturation Model: One More Historical Myth. Eur Urol Focus. 2019 01; 5(1):81-89. PMID: 28753828.
    Citations:    Fields:    
  14. Krakowsky Y, Conners W, Morgentaler A. Serum Concentrations of Sex Hormone-binding Globulin Vary Widely in Younger and Older Men: Clinical Data from a Men's Health Practice. Eur Urol Focus. 2019 03; 5(2):273-279. PMID: 28753796.
    Citations:    Fields:    
  15. Corona G, Rastrelli G, Morgentaler A, Sforza A, Mannucci E, Maggi M. Meta-analysis of Results of Testosterone Therapy on Sexual Function Based on International Index of Erectile Function Scores. Eur Urol. 2017 12; 72(6):1000-1011. PMID: 28434676.
    Citations: 6     Fields:    Translation:Humans
  16. Morgentaler A. Andrology: Testosterone reference ranges and diagnosis of testosterone deficiency. Nat Rev Urol. 2017 May; 14(5):263-264. PMID: 28266512.
    Citations:    Fields:    
  17. Salonia A, Adaikan G, Buvat J, Carrier S, El-Meliegy A, Hatzimouratidis K, McCullough A, Morgentaler A, Torres LO, Khera M. Sexual Rehabilitation After Treatment for Prostate Cancer-Part 1: Recommendations From the Fourth International Consultation for Sexual Medicine (ICSM 2015). J Sex Med. 2017 Mar; 14(3):285-296. PMID: 28262099.
    Citations: 2     Fields:    Translation:Humans
  18. Salonia A, Adaikan G, Buvat J, Carrier S, El-Meliegy A, Hatzimouratidis K, McCullough A, Morgentaler A, Torres LO, Khera M. Sexual Rehabilitation After Treatment For Prostate Cancer-Part 2: Recommendations From the Fourth International Consultation for Sexual Medicine (ICSM 2015). J Sex Med. 2017 Mar; 14(3):297-315. PMID: 28262100.
    Citations: 4     Fields:    Translation:Humans
  19. Traish AM, Vance JC, Morgentaler A. Overselling hysteria: The role of the media and medical journals in promoting questionable risks-a case study of the testosterone controversy. EMBO Rep. 2017 01; 18(1):11-17. PMID: 27920032.
    Citations:    Fields:    Translation:Humans
  20. Khera M, Adaikan G, Buvat J, Carrier S, El-Meliegy A, Hatzimouratidis K, McCullough A, Morgentaler A, Torres LO, Salonia A. Diagnosis and Treatment of Testosterone Deficiency: Recommendations From the Fourth International Consultation for Sexual Medicine (ICSM 2015). J Sex Med. 2016 12; 13(12):1787-1804. PMID: 27914560.
    Citations: 4     Fields:    Translation:Humans
  21. Morgentaler A. Testosterone Therapy Can be Given to Men with No Concern that it will Promote Prostate Cancer Development or Progression: Pro. J Urol. 2016 Oct; 196(4):985-8. PMID: 27449261.
    Citations: 2     Fields:    Translation:Humans
  22. Morgentaler A, Zitzmann M, Traish AM, Fox AW, Jones TH, Maggi M, Arver S, Aversa A, Chan JC, Dobs AS, Hackett GI, Hellstrom WJ, Lim P, Lunenfeld B, Mskhalaya G, Schulman CC, Torres LO. Fundamental Concepts Regarding Testosterone Deficiency and Treatment: International Expert Consensus Resolutions. Mayo Clin Proc. 2016 07; 91(7):881-96. PMID: 27313122.
    Citations: 12     Fields:    Translation:Humans
  23. Davidson E, Morgentaler A. Testosterone Therapy and Prostate Cancer. Urol Clin North Am. 2016 May; 43(2):209-16. PMID: 27132578.
    Citations: 1     Fields:    Translation:Humans
  24. Brandon M, Morgentaler A. Male and Female Sexual Dysfunction in a Rapidly Changing Cultural Environment: Addressing Gender Equality versus Equivalence in the Bedroom. Sex Med Rev. 2016 04; 4(2):96-102. PMID: 27872026.
    Citations:    Fields:    Translation:Humans
  25. Kacker R, Hult M, San Francisco IF, Conners WP, Rojas PA, Dewolf WC, Morgentaler A. Can testosterone therapy be offered to men on active surveillance for prostate cancer? Preliminary results. Asian J Androl. 2016 Jan-Feb; 18(1):16-20. PMID: 26306850.
    Citations: 10     Fields:    Translation:Humans
  26. Kaplan AL, Hu JC, Morgentaler A, Mulhall JP, Schulman CC, Montorsi F. Testosterone Therapy in Men With Prostate Cancer. Eur Urol. 2016 05; 69(5):894-903. PMID: 26719015.
    Citations: 6     Fields:    Translation:Humans
  27. Morgentaler A. Controversies and Advances With Testosterone Therapy: A 40-Year Perspective. Urology. 2016 Mar; 89:27-32. PMID: 26683750.
    Citations: 7     Fields:    Translation:Humans
  28. Paduch DA, Polzer P, Morgentaler A, Althof S, Donatucci C, Ni X, Patel AB, Basaria S. Response and Rebuttal to Editorial Comment on: Clinical and Demographic Correlates of Ejaculatory Dysfunctions Other than Premature Ejaculation: A Prospective, Observational Study. J Sex Med. 2015 Dec; 12(12):2289-90. PMID: 26696224.
    Citations:    
  29. Morgentaler A, Zitzmann M, Traish AM, Fox A. International expert consensus conference on testosterone deficiency and its treatment held in Prague, Czech Republic. Aging Male. 2015; 18(4):205-6. PMID: 26586191.
    Citations:    Fields:    Translation:Humans
  30. Paduch DA, Polzer P, Morgentaler A, Althof S, Donatucci C, Ni X, Patel AB, Basaria S. Clinical and Demographic Correlates of Ejaculatory Dysfunctions Other Than Premature Ejaculation: A Prospective, Observational Study. J Sex Med. 2015 Dec; 12(12):2276-86. PMID: 26511106.
    Citations: 4     Fields:    Translation:Humans
  31. Aversa A, Morgentaler A. The practical management of testosterone deficiency in men. Nat Rev Urol. 2015 11; 12(11):641-50. PMID: 26458755.
    Citations: 8     Fields:    Translation:Humans
  32. Dean JD, McMahon CG, Guay AT, Morgentaler A, Althof SE, Becher EF, Bivalacqua TJ, Burnett AL, Buvat J, El Meliegy A, Hellstrom WJ, Jannini EA, Maggi M, McCullough A, Torres LO, Zitzmann M. The International Society for Sexual Medicine's Process of Care for the Assessment and Management of Testosterone Deficiency in Adult Men. J Sex Med. 2015 Aug; 12(8):1660-86. PMID: 26081680.
    Citations: 16     Fields:    Translation:Humans
  33. Baillargeon J, Urban RJ, Morgentaler A, Glueck CJ, Baillargeon G, Sharma G, Kuo YF. Risk of Venous Thromboembolism in Men Receiving Testosterone Therapy. Mayo Clin Proc. 2015 Aug; 90(8):1038-45. PMID: 26205547.
    Citations: 8     Fields:    Translation:Humans
  34. Pastuszak AW, Khanna A, Badhiwala N, Morgentaler A, Hult M, Conners WP, Sarosdy MF, Yang C, Carrion R, Lipshultz LI, Khera M. Testosterone Therapy after Radiation Therapy for Low, Intermediate and High Risk Prostate Cancer. J Urol. 2015 Nov; 194(5):1271-6. PMID: 26025500.
    Citations: 7     Fields:    Translation:Humans
  35. Morgentaler A, Conners WP. Testosterone therapy in men with prostate cancer: literature review, clinical experience, and recommendations. Asian J Androl. 2015 Mar-Apr; 17(2):206-11. PMID: 25652633.
    Citations: 3     Fields:    Translation:Humans
  36. Morgentaler A, Feibus A, Baum N. Testosterone and cardiovascular disease--the controversy and the facts. Postgrad Med. 2015 Mar; 127(2):159-65. PMID: 25708023.
    Citations: 1     Fields:    Translation:Humans
  37. Baillargeon J, Urban RJ, Kuo YF, Holmes HM, Raji MA, Morgentaler A, Howrey BT, Lin YL, Ottenbacher KJ. Screening and monitoring in men prescribed testosterone therapy in the U.S., 2001-2010. Public Health Rep. 2015 Mar-Apr; 130(2):143-52. PMID: 25729103.
    Citations: 2     Fields:    Translation:Humans
  38. Lunenfeld B, Mskhalaya G, Zitzmann M, Arver S, Kalinchenko S, Tishova Y, Morgentaler A. Recommendations on the diagnosis, treatment and monitoring of hypogonadism in men. Aging Male. 2015 Mar; 18(1):5-15. PMID: 25657080.
    Citations: 24     Fields:    Translation:Humans
  39. Morgentaler A, Miner MM, Caliber M, Guay AT, Khera M, Traish AM. Testosterone therapy and cardiovascular risk: advances and controversies. Mayo Clin Proc. 2015 Feb; 90(2):224-51. PMID: 25636998.
    Citations: 36     Fields:    Translation:Humans
  40. Morgentaler A. Testosterone deficiency and cardiovascular mortality. Asian J Androl. 2015 Jan-Feb; 17(1):26-31. PMID: 25432501.
    Citations: 5     Fields:    Translation:Humans
  41. Traish AM, Morgentaler A, Khera M. RE: Testosterone treatment is a potent tumor promoter for the rat prostate. Endocrinology. 2015 Jan; 156(1):L1-2. PMID: 25526553.
    Citations:    Fields:    Translation:Animals
  42. Zarotsky V, Huang MY, Carman W, Morgentaler A, Singhal PK, Coffin D, Jones TH. Systematic literature review of the risk factors, comorbidities, and consequences of hypogonadism in men. Andrology. 2014 Nov; 2(6):819-34. PMID: 25269643.
    Citations: 18     Fields:    Translation:Humans
  43. Morgentaler A, Benesh JA, Denes BS, Kan-Dobrosky N, Harb D, Miller MG. Factors influencing prostate-specific antigen response among men treated with testosterone therapy for 6 months. J Sex Med. 2014 Nov; 11(11):2818-25. PMID: 25131184.
    Citations: 11     Fields:    Translation:Humans
  44. Morgentaler A, McGettigan J, Xiang Q, Danoff TM, Gould EM. Pharmacokinetics and drying time of testosterone 2% gel in men with hypogonadism: a multicenter, open-label, single-arm trial. Int J Impot Res. 2015 Mar-Apr; 27(2):41-5. PMID: 25056809.
    Citations:    Fields:    Translation:HumansCTClinical Trials
  45. Balbontin FG, Moreno SA, Bley E, Chacon R, Silva A, Morgentaler A. Long-acting testosterone injections for treatment of testosterone deficiency after brachytherapy for prostate cancer. BJU Int. 2014 Jul; 114(1):125-30. PMID: 25101359.
    Citations: 9     Fields:    Translation:Humans
  46. Morgentaler A. Will I have a heart attack or stroke if I take testosterone therapy? J Sex Med. 2014 Jun; 11(6):1601-2. PMID: 24905250.
    Citations: 2     Fields:    Translation:Humans
  47. Kacker R, Morgentaler A, Traish A. Medical hypothesis: loss of the endocrine function of the prostate is important to the pathophysiology of postprostatectomy erectile dysfunction. J Sex Med. 2014 Aug; 11(8):1898-902. PMID: 24836599.
    Citations:    Fields:    Translation:HumansAnimals
  48. Morgentaler A, Lunenfeld B. Testosterone and cardiovascular risk: world's experts take unprecedented action to correct misinformation. Aging Male. 2014 Jun; 17(2):63-5. PMID: 24797617.
    Citations: 7     Fields:    Translation:Humans
  49. San Francisco IF, Rojas PA, DeWolf WC, Morgentaler A. Low free testosterone levels predict disease reclassification in men with prostate cancer undergoing active surveillance. BJU Int. 2014 Aug; 114(2):229-35. PMID: 24898919.
    Citations: 14     Fields:    Translation:HumansPHPublic Health
  50. Khera M, Morgentaler A. Reply to Julia Klap and Kevin R. Loughlin's letter to the editor re: Mohit Khera, David Crawford, Alvaro Morales, Andrea Salonia, Abraham Morgentaler. A new era of testosterone and prostate cancer: from physiology to clinical implications. Eur Urol 2014;65:115-23. Eur Urol. 2014 Aug; 66(2):e33. PMID: 24836155.
    Citations:    Fields:    Translation:Humans
  51. Morgentaler A. Testosterone, cardiovascular risk, and hormonophobia. J Sex Med. 2014 Jun; 11(6):1362-6. PMID: 24787518.
    Citations: 6     Fields:    Translation:Humans
  52. Morgentaler A, Khera M, Maggi M, Zitzmann M. Commentary: Who is a candidate for testosterone therapy? A synthesis of international expert opinions. J Sex Med. 2014 Jul; 11(7):1636-45. PMID: 24797325.
    Citations: 14     Fields:    Translation:Humans
  53. Morgentaler A. New concepts regarding testosterone and prostate cancer: a breath of fresh air. Oncology (Williston Park). 2014 May; 28(5):404-5. PMID: 25004654.
    Citations:    Fields:    Translation:Humans
  54. Seftel AD, Morgentaler A. Does testosterone increase the risk of a cardiovascular event? J Urol. 2014 Jul; 192(1):13-5. PMID: 24746882.
    Citations: 1     Fields:    Translation:Humans
  55. Morgentaler A, Traish A, Kacker R. Deaths and cardiovascular events in men receiving testosterone. JAMA. 2014 Mar 05; 311(9):961-2. PMID: 24595783.
    Citations: 5     Fields:    Translation:Humans
  56. Traish AM, Guay AT, Morgentaler A. Death by testosterone? We think not! J Sex Med. 2014 Mar; 11(3):624-9. PMID: 24589170.
    Citations: 12     Fields:    Translation:Humans
  57. Morgentaler A, Kacker R. Andrology: Testosterone and cardiovascular risk--deciphering the statistics. Nat Rev Urol. 2014 Mar; 11(3):131-2. PMID: 24535586.
    Citations: 6     Fields:    Translation:Humans
  58. Kacker R, Harisaran V, Given L, Miner M, Rittmaster R, Morgentaler A. Dutasteride in men receiving testosterone therapy: a randomised, double-blind study. Andrologia. 2015 Mar; 47(2):148-52. PMID: 24499051.
    Citations:    Fields:    Translation:Humans
  59. Gooren L, Morgentaler A. Prostate cancer incidence in orchidectomised male-to-female transsexual persons treated with oestrogens. Andrologia. 2014 Dec; 46(10):1156-60. PMID: 24329588.
    Citations: 8     Fields:    Translation:Humans
  60. Conners WP, Morgentaler A. The evaluation and management of testosterone deficiency: the new frontier in urology and men's health. Curr Urol Rep. 2013 Dec; 14(6):557-64. PMID: 23999611.
    Citations:    Fields:    Translation:Humans
  61. Kacker R, Conners W, Zade J, Morgentaler A. Bone mineral density and response to treatment in men younger than 50 years with testosterone deficiency and sexual dysfunction or infertility. J Urol. 2014 Apr; 191(4):1072-6. PMID: 24161998.
    Citations: 5     Fields:    Translation:Humans
  62. Kacker R, Hornstein A, Morgentaler A. Free testosterone by direct and calculated measurement versus equilibrium dialysis in a clinical population. Aging Male. 2013 Dec; 16(4):164-8. PMID: 24090209.
    Citations: 9     Fields:    Translation:HumansCells
  63. Linares Espinós E, Martínez-Salamanca JI, Morgentaler A, Moncada I, del Portillo L, Rodríguez-Izquierdo M, Areche J, Carballido J. [Patient with testosterone deficit syndrome after radical prostatectomy]. Arch Esp Urol. 2013 Sep; 66(7):663-8. PMID: 24047624.
    Citations:    Fields:    Translation:Humans
  64. Khera M, Crawford D, Morales A, Salonia A, Morgentaler A. A new era of testosterone and prostate cancer: from physiology to clinical implications. Eur Urol. 2014 Jan; 65(1):115-23. PMID: 24011426.
    Citations: 30     Fields:    Translation:Humans
  65. Traish AM, Morgentaler A. Re: effect of finasteride on serum levels of androstenedione, testosterone and their 5a-reduced metabolites in men at risk for prostate cancer. J Steroid Biochem Mol Biol. 2013 Nov; 138:462. PMID: 23851167.
    Citations:    Fields:    Translation:Humans
  66. Morgentaler A. Testosterone therapy in men with prostate cancer: scientific and ethical considerations. J Urol. 2013 Jan; 189(1 Suppl):S26-33. PMID: 23234627.
    Citations: 5     Fields:    Translation:HumansAnimals
  67. Morgentaler A. Goodbye androgen hypothesis, hello saturation model. Eur Urol. 2012 Nov; 62(5):765-7. PMID: 22728116.
    Citations: 6     Fields:    Translation:Humans
  68. Morgentaler A. Low testosterone levels are related to poor prognosis factors in men with prostate cancer prior to treatment. BJU Int. 2012 Dec; 110(11 Pt B):E547. PMID: 22583384.
    Citations: 1     Fields:    Translation:Humans
  69. Kacker R, Traish AM, Morgentaler A. Estrogens in men: clinical implications for sexual function and the treatment of testosterone deficiency. J Sex Med. 2012 Jun; 9(6):1681-96. PMID: 22512993.
    Citations: 5     Fields:    Translation:Humans
  70. McCullough AR, Khera M, Goldstein I, Hellstrom WJ, Morgentaler A, Levine LA. A multi-institutional observational study of testosterone levels after testosterone pellet (Testopel(®)) insertion. J Sex Med. 2012 Feb; 9(2):594-601. PMID: 22240203.
    Citations: 10     Fields:    Translation:Humans
  71. Di Sante S, Conners WP, Morgentaler A. Influence of baseline serum testosterone on changes in body composition in response to testosterone therapy. J Sex Med. 2012 Feb; 9(2):585-93. PMID: 22145684.
    Citations: 2     Fields:    Translation:Humans
  72. Conners W, Flinn K, Morgentaler A. Outcomes with the "V" implantation technique vs. standard technique for testosterone pellet therapy. J Sex Med. 2011 Dec; 8(12):3465-70. PMID: 21883944.
    Citations: 1     Fields:    Translation:Humans
  73. Traish AM, Miner MM, Morgentaler A, Zitzmann M. Testosterone deficiency. Am J Med. 2011 Jul; 124(7):578-87. PMID: 21683825.
    Citations: 36     Fields:    Translation:Humans
  74. Morgentaler A. Testosterone and prostate cancer: what are the risks for middle-aged men? Urol Clin North Am. 2011 May; 38(2):119-24. PMID: 21621078.
    Citations: 8     Fields:    Translation:Humans
  75. Jannini EA, Gravina GL, Morgentaler A, Mortengaler A, Morales A, Incrocci L, Hellstrom WJ. Is testosterone a friend or a foe of the prostate? J Sex Med. 2011 Apr; 8(4):946-55. PMID: 21457469.
    Citations: 5     Fields:    Translation:Humans
  76. Morgentaler A. Words of wisdom. Re: Adverse events associated with testosterone administration. Eur Urol. 2011 Mar; 59(3):465. PMID: 21414881.
    Citations: 2     Fields:    
  77. Morgentaler A. Turning conventional wisdom upside-down: low serum testosterone and high-risk prostate cancer. Cancer. 2011 Sep 01; 117(17):3885-8. PMID: 21365620.
    Citations: 5     Fields:    Translation:Humans
  78. Morgentaler A, Lipshultz LI, Bennett R, Sweeney M, Avila D, Khera M. Testosterone therapy in men with untreated prostate cancer. J Urol. 2011 Apr; 185(4):1256-60. PMID: 21334649.
    Citations: 32     Fields:    Translation:Humans
  79. Rosen RC, Araujo AB, Connor MK, Gerstenberger EP, Morgentaler A, Seftel AD, Miner MM, Shabsigh R. The NERI Hypogonadism Screener: psychometric validation in male patients and controls. Clin Endocrinol (Oxf). 2011 Feb; 74(2):248-56. PMID: 21114509.
    Citations: 6     Fields:    Translation:Humans
  80. Morgentaler A, Morales A. Should hypogonadal men with prostate cancer receive testosterone? J Urol. 2010 Oct; 184(4):1257-60. PMID: 20723918.
    Citations: 2     Fields:    Translation:Humans
  81. Buvat J, Maggi M, Gooren L, Guay AT, Kaufman J, Morgentaler A, Schulman C, Tan HM, Torres LO, Yassin A, Zitzmann M. Endocrine aspects of male sexual dysfunctions. J Sex Med. 2010 Apr; 7(4 Pt 2):1627-56. PMID: 20388162.
    Citations: 25     Fields:    Translation:HumansPHPublic Health
  82. Morgentaler A, Rhoden EL, Guay A, Traish A. Serum testosterone is associated with aggressive prostate cancer in older men: results from the Baltimore Longitudinal Study of Aging. BJU Int. 2010 Mar; 105(6):884-5; author reply 885-6. PMID: 20353537.
    Citations:    Fields:    Translation:Humans
  83. Glina S, Rivero MA, Morales A, Morgentaler A. Studies on prostatic cancer I. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate by Charles Huggins and Clarence V. Hodges. J Sex Med. 2010 Feb; 7(2 Pt 1):640-4. PMID: 20492413.
    Citations: 3     Fields:    Translation:HumansAnimals
  84. Rhoden EL, Morgentaler A. Symptomatic response rates to testosterone therapy and the likelihood of completing 12 months of therapy in clinical practice. J Sex Med. 2010 Jan; 7(1 Pt 1):277-83. PMID: 20104673.
    Citations: 4     Fields:    Translation:Humans
  85. Heldwein FL, Rhoden EL, Morgentaler A. Classics of urology: a half century history of the most frequently cited articles (1955-2009). Urology. 2010 Jun; 75(6):1261-8. PMID: 19962736.
    Citations: 17     Fields:    Translation:Humans
  86. Traish AM, Morgentaler A. Epidermal growth factor receptor expression escapes androgen regulation in prostate cancer: a potential molecular switch for tumour growth. Br J Cancer. 2009 Dec 15; 101(12):1949-56. PMID: 19888222.
    Citations: 27     Fields:    Translation:HumansCells
  87. Moreno SA, Shyam A, Morgentaler A. Comparison of free testosterone results by analog radioimmunoassay and calculated free testosterone in an ambulatory clinical population. J Sex Med. 2010 May; 7(5):1948-53. PMID: 19732301.
    Citations: 6     Fields:    Translation:Humans
  88. Morgentaler A. Rapidly shifting concepts regarding androgens and prostate cancer. ScientificWorldJournal. 2009 Jul 27; 9:685-90. PMID: 19649507.
    Citations: 5     Fields:    Translation:Humans
  89. Rosen RC, Araujo AB, Connor MK, Elstad EA, McGraw SA, Guay AT, Morgentaler A, Miner MM. Assessing symptoms of hypogonadism by self-administered questionnaire: qualitative findings in patients and controls. Aging Male. 2009 Jun-Sep; 12(2-3):77-85. PMID: 19811219.
    Citations: 4     Fields:    Translation:HumansPHPublic Health
  90. Isbarn H, Pinthus JH, Marks LS, Montorsi F, Morales A, Morgentaler A, Schulman C. Testosterone and prostate cancer: revisiting old paradigms. Eur Urol. 2009 Jul; 56(1):48-56. PMID: 19375844.
    Citations: 22     Fields:    Translation:Humans
  91. Moreno SA, Morgentaler A. Testosterone deficiency and Peyronie's disease: pilot data suggesting a significant relationship. J Sex Med. 2009 Jun; 6(6):1729-1735. PMID: 19473459.
    Citations: 7     Fields:    Translation:Humans
  92. Morgentaler A. Two years of testosterone therapy associated with decline in prostate-specific antigen in a man with untreated prostate cancer. J Sex Med. 2009 Feb; 6(2):574-7. PMID: 19215619.
    Citations: 10     Fields:    Translation:Humans
  93. Morgentaler A. Testosterone therapy in men with prostate cancer: scientific and ethical considerations. J Urol. 2009 Mar; 181(3):972-9. PMID: 19150547.
    Citations: 8     Fields:    Translation:HumansAnimals
  94. Morgentaler A, Schulman C. Testosterone and prostate safety. Front Horm Res. 2009; 37:197-203. PMID: 19011298.
    Citations: 2     Fields:    Translation:Humans
  95. Morgentaler A, Dobs AS, Kaufman JM, Miner MM, Shabsigh R, Swerdloff RS, Wang C. Long acting testosterone undecanoate therapy in men with hypogonadism: results of a pharmacokinetic clinical study. J Urol. 2008 Dec; 180(6):2307-13. PMID: 18930255.
    Citations: 3     Fields:    Translation:Humans
  96. Dobs AS, Morgentaler A. Does testosterone therapy increase the risk of prostate cancer? Endocr Pract. 2008 Oct; 14(7):904-11. PMID: 18996823.
    Citations: 2     Fields:    Translation:Humans
  97. Morgentaler A, Traish AM. Shifting the paradigm of testosterone and prostate cancer: the saturation model and the limits of androgen-dependent growth. Eur Urol. 2009 Feb; 55(2):310-20. PMID: 18838208.
    Citations: 92     Fields:    Translation:HumansAnimalsCells
  98. Morgentaler A. Guilt by association: a historical perspective on Huggins, testosterone therapy, and prostate cancer. J Sex Med. 2008 Aug; 5(8):1834-40. PMID: 18547385.
    Citations: 4     Fields:    Translation:Humans
  99. Lazarou S, Morgentaler A. The effect of aging on spermatogenesis and pregnancy outcomes. Urol Clin North Am. 2008 May; 35(2):331-9, xi. PMID: 18423252.
    Citations: 1     Fields:    Translation:HumansCells
  100. Morgentaler A. Re: effect of testosterone supplementation on functional mobility, cognition, and other parameters in older men: a randomized controlled trial. Eur Urol. 2008 May; 53(5):1084. PMID: 18485319.
    Citations: 1     Fields:    
  101. Morgentaler A. Response to: Efficacy of changing testosterone gel preparations (Androgel or Testim) among suboptimally responsive hypogonadal men. Int J Impot Res. 2008 May-Jun; 20(3):331; author reply 332. PMID: 18475269.
    Citations:    Fields:    Translation:Humans
  102. Rhoden EL, Riedner CE, Morgentaler A. The ratio of serum testosterone-to-prostate specific antigen predicts prostate cancer in hypogonadal men. J Urol. 2008 May; 179(5):1741-4. PMID: 18343420.
    Citations: 3     Fields:    Translation:Humans
  103. Morgentaler A. Testosterone replacement therapy and prostate cancer. Urol Clin North Am. 2007 Nov; 34(4):555-63, vii. PMID: 17983895.
    Citations: 13     Fields:    Translation:Humans
  104. Crawford ED, Barqawi AB, O'Donnell C, Morgentaler A. The association of time of day and serum testosterone concentration in a large screening population. BJU Int. 2007 Sep; 100(3):509-13. PMID: 17555474.
    Citations: 9     Fields:    Translation:HumansPHPublic Health
  105. Mulhall JP, Morgentaler A. Penile rehabilitation should become the norm for radical prostatectomy patients. J Sex Med. 2007 May; 4(3):538-543. PMID: 17498093.
    Citations: 24     Fields:    Translation:Humans
  106. Morgentaler A. Re: The interpretation of serum prostate specific antigen in men receiving 5alpha-reductase inhibitors: a review and clinical recommendations. J Urol. 2007 May; 177(5):1954. PMID: 17437855.
    Citations:    Fields:    Translation:Humans
  107. Morgentaler A. Testosterone deficiency and prostate cancer: emerging recognition of an important and troubling relationship. Eur Urol. 2007 Sep; 52(3):623-5. PMID: 17433531.
    Citations: 10     Fields:    Translation:Humans
  108. Morgentaler A. New concepts regarding the relationship of testosterone and prostate cancer. Future Oncol. 2007 Apr; 3(2):123-6. PMID: 17381410.
    Citations: 2     Fields:    Translation:Humans
  109. Morgentaler A. Re: Masashi Yano, Takashi Imamoto, Hiroyoshi Suzuki et Al. The clinical potential of pretreatment serum testosterone level to improve the efficiency of prostate cancer screening. Eur urol 2007;51:375-80. Eur Urol. 2007 Jul; 52(1):292; author reply 293-4. PMID: 17400361.
    Citations:    Fields:    Translation:HumansPHPublic Health
  110. Morgentaler A. Cultural biases and scientific squabbles: the challenges to acceptance of testosterone therapy as a mainstream medical treatment. Aging Male. 2007 Mar; 10(1):1-2. PMID: 17454976.
    Citations:    Fields:    Translation:Humans
  111. Morgentaler A. Commentary: Guideline for male testosterone therapy: a clinician's perspective. J Clin Endocrinol Metab. 2007 Feb; 92(2):416-7. PMID: 17284642.
    Citations: 5     Fields:    Translation:Humans
  112. Lux M, Reyes-Vallejo L, Morgentaler A, Levine LA. Outcomes and satisfaction rates for the redesigned 2-piece penile prosthesis. J Urol. 2007 Jan; 177(1):262-6. PMID: 17162061.
    Citations: 8     Fields:    Translation:Humans
  113. Morgentaler A, Rhoden EL. Prevalence of prostate cancer among hypogonadal men with prostate-specific antigen levels of 4.0 ng/mL or less. Urology. 2006 Dec; 68(6):1263-7. PMID: 17169647.
    Citations: 38     Fields:    Translation:Humans
  114. Reyes-Vallejo L, Lazarou S, Morgentaler A. Subjective sexual response to testosterone replacement therapy based on initial serum levels of total testosterone. J Sex Med. 2007 Nov; 4(6):1757-62. PMID: 17087806.
    Citations: 6     Fields:    Translation:Humans
  115. Lazarou S, Reyes-Vallejo L, Morgentaler A. Wide variability in laboratory reference values for serum testosterone. J Sex Med. 2006 Nov; 3(6):1085-1089. PMID: 17100942.
    Citations: 11     Fields:    Translation:Humans
  116. Morgentaler A. Testosterone therapy for men at risk for or with history of prostate cancer. Curr Treat Options Oncol. 2006 Sep; 7(5):363-9. PMID: 16904053.
    Citations: 6     Fields:    Translation:Humans
  117. Morgentaler A. Testosterone and prostate cancer: an historical perspective on a modern myth. Eur Urol. 2006 Nov; 50(5):935-9. PMID: 16875775.
    Citations: 49     Fields:    Translation:Humans
  118. Lazarou S, Reyes-Vallejo L, Morgentaler A. Phleboliths in varicoceles presenting as spermatic cord mass. Fertil Steril. 2006 Jul; 86(1):219.e21-2. PMID: 16818036.
    Citations:    Fields:    Translation:Humans
  119. Morgentaler A, Barada J, Niederberger C, Donatucci C, Garcia CS, Natanegara F, Ahuja S, Wong DG. Efficacy and safety of tadalafil across ethnic groups and various risk factors in men with erectile dysfunction: Use of a novel noninferiority study design. J Sex Med. 2006 May; 3(3):492-503. PMID: 16681475.
    Citations: 4     Fields:    Translation:HumansCTClinical Trials
  120. Morgentaler A, Rhoden EL, Barqawi AB, Crawford ED. Re: Prostate cancer in men using testosterone supplementation. F. D. Gaylis, D. W. Lin, J. M. Ignatoff, C. L. Amling, R. F. Tutrone and D. J. Cosgrove. J Urol. 2006 Apr; 175(4):1572; author reply 1573-4. PMID: 16516047.
    Citations:    Fields:    Translation:Humans
  121. Rhoden EL, Morgentaler A. Influence of demographic factors and biochemical characteristics on the prostate-specific antigen (PSA) response to testosterone replacement therapy. Int J Impot Res. 2006 Mar-Apr; 18(2):201-5. PMID: 16177827.
    Citations: 6     Fields:    Translation:Humans
  122. Reyes-Vallejo L, Lazarou S, Morgentaler A. Y chromosome microdeletions and male infertility: who should be tested and why? BJU Int. 2006 Mar; 97(3):441-3. PMID: 16469004.
    Citations: 2     Fields:    Translation:HumansCells
  123. Morgentaler A. Testosterone replacement therapy and prostate risks: where's the beef? Can J Urol. 2006 Feb; 13 Suppl 1:40-3. PMID: 16526980.
    Citations: 4     Fields:    Translation:Humans
  124. Lazarou S, Reyes-Vallejo L, Morgentaler A. Technical advances in penile prostheses. J Long Term Eff Med Implants. 2006; 16(3):235-47. PMID: 17073566.
    Citations:    Fields:    Translation:Humans
  125. Lazarou S, Morgentaler A. Hypogonadism in the man with erectile dysfunction: what to look for and when to treat. Curr Urol Rep. 2005 Nov; 6(6):476-81. PMID: 16238923.
    Citations: 2     Fields:    Translation:Humans
  126. Ramsawh HJ, Morgentaler A, Covino N, Barlow DH, DeWolf WC. Quality of life following simultaneous placement of penile prosthesis with radical prostatectomy. J Urol. 2005 Oct; 174(4 Pt 1):1395-8. PMID: 16145445.
    Citations: 4     Fields:    Translation:Humans
  127. Cady B, Barker F, Easson A, Aboulafia AJ, Ferson PF, Miner T, Morgentaler A. Part 3: surgical palliation of advanced illness: what's new, what's helpful. J Am Coll Surg. 2005 Mar; 200(3):457-66. PMID: 15737858.
    Citations:    Fields:    Translation:Humans
  128. Cady B, Miner T, Morgentaler A. Part 2: Surgical palliation of advanced illness: what's new, what's helpful. J Am Coll Surg. 2005 Feb; 200(2):281-90. PMID: 15664106.
    Citations:    Fields:    Translation:Humans
  129. Morgentaler A. A 66-year-old man with sexual dysfunction. JAMA. 2004 Jun 23; 291(24):2994-3003. PMID: 15213212.
    Citations: 2     Fields:    Translation:Humans
  130. Rhoden EL, Morgentaler A. Treatment of testosterone-induced gynecomastia with the aromatase inhibitor, anastrozole. Int J Impot Res. 2004 Feb; 16(1):95-7. PMID: 14963480.
    Citations: 7     Fields:    Translation:Humans
  131. Rhoden EL, Morgentaler A. Risks of testosterone-replacement therapy and recommendations for monitoring. N Engl J Med. 2004 Jan 29; 350(5):482-92. PMID: 14749457.
    Citations: 94     Fields:    Translation:Humans
  132. Rhoden EL, Morgentaler A. Testosterone replacement therapy in hypogonadal men at high risk for prostate cancer: results of 1 year of treatment in men with prostatic intraepithelial neoplasia. J Urol. 2003 Dec; 170(6 Pt 1):2348-51. PMID: 14634413.
    Citations: 36     Fields:    Translation:Humans
  133. Rhoden EL, Gobbi D, Rhoden CR, Menti E, Roehe AN, Hartmann A, Morgentaler A. Effects of chronic administration of dehydroepiandrosterone on serum testosterone levels and prostatic tissue in rats. J Urol. 2003 Nov; 170(5):2101-3. PMID: 14532863.
    Citations: 1     Fields:    Translation:Animals
  134. Rhoden EL, Estrada C, Levine L, Morgentaler A. The value of pituitary magnetic resonance imaging in men with hypogonadism. J Urol. 2003 Sep; 170(3):795-8. PMID: 12913700.
    Citations: 11     Fields:    Translation:Humans
  135. Rhoden EL, Morgentaler A. Erectile dysfunction. J Long Term Eff Med Implants. 2003; 13(6):519-28. PMID: 15056069.
    Citations:    Fields:    Translation:Humans
  136. Yin Y, Stahl BC, DeWolf WC, Morgentaler A. P53 and Fas are sequential mechanisms of testicular germ cell apoptosis. J Androl. 2002 Jan-Feb; 23(1):64-70. PMID: 11780924.
    Citations: 24     Fields:    Translation:Animals
  137. Levine LA, Estrada CR, Morgentaler A. Mechanical reliability and safety of, and patient satisfaction with the Ambicor inflatable penile prosthesis: results of a 2 center study. J Urol. 2001 Sep; 166(3):932-7. PMID: 11490249.
    Citations: 16     Fields:    Translation:Humans
  138. Hoffman MA, DeWolf WC, Morgentaler A. Is low serum free testosterone a marker for high grade prostate cancer? J Urol. 2000 Mar; 163(3):824-7. PMID: 10687985.
    Citations: 53     Fields:    Translation:Humans
  139. Morgentaler A. Male impotence. Lancet. 1999 Nov 13; 354(9191):1713-8. PMID: 10568586.
    Citations: 5     Fields:    Translation:Humans
  140. Morgentaler A, Stahl BC, Yin Y. Testis and temperature: an historical, clinical, and research perspective. J Androl. 1999 Mar-Apr; 20(2):189-95. PMID: 10232653.
    Citations: 10     Fields:    Translation:Humans
  141. Yin Y, Stahl BC, DeWolf WC, Morgentaler A. p53-mediated germ cell quality control in spermatogenesis. Dev Biol. 1998 Dec 01; 204(1):165-71. PMID: 9851850.
    Citations: 23     Fields:    Translation:AnimalsCells
  142. Yin Y, Stahl BC, DeWolf WC, Morgentaler A. Heat-induced testicular apoptosis occurs independently of hormonal depletion. Apoptosis. 1998 Sep; 3(4):281-7. PMID: 14646492.
    Citations: 3     Fields:    
  143. Morgentaler A. Motile organisms in the epididymis? Hum Reprod. 1998 Aug; 13(8):2335. PMID: 9756322.
    Citations:    Fields:    Translation:HumansAnimalsCells
  144. Khoudary KP, Morgentaler A. Partial duplication of the vas deferens. J Urol. 1998 Mar; 159(3):988-9. PMID: 9474205.
    Citations: 4     Fields:    Translation:Humans
  145. Yin Y, DeWolf WC, Morgentaler A. Experimental cryptorchidism induces testicular germ cell apoptosis by p53-dependent and -independent pathways in mice. Biol Reprod. 1998 Feb; 58(2):492-6. PMID: 9475406.
    Citations: 21     Fields:    Translation:AnimalsCells
  146. Morgentaler A. Causality and association--more than just different shades of gray. Fertil Steril. 1997 Oct; 68(4):745. PMID: 9341625.
    Citations:    Fields:    Translation:Humans
  147. Khoudary KP, DeWolf WC, Bruning CO, Morgentaler A. Immediate sexual rehabilitation by simultaneous placement of penile prosthesis in patients undergoing radical prostatectomy: initial results in 50 patients. Urology. 1997 Sep; 50(3):395-9. PMID: 9301704.
    Citations: 3     Fields:    Translation:Humans
  148. Yin Y, DeWolf WC, Morgentaler A. p53 is associated with the nuclear envelope in mouse testis. Biochem Biophys Res Commun. 1997 Jun 27; 235(3):689-94. PMID: 9207221.
    Citations: 1     Fields:    Translation:AnimalsCells
  149. Socher SA, Yin Y, Dewolf WC, Morgentaler A. Temperature-mediated germ cell loss in the testis is associated with altered expression of the cell-cycle regulator p53. J Urol. 1997 May; 157(5):1986-9. PMID: 9112577.
    Citations: 4     Fields:    Translation:AnimalsCells
  150. Vohra S, Morgentaler A. Congenital anomalies of the vas deferens, epididymis, and seminal vesicles. Urology. 1997 Mar; 49(3):313-21. PMID: 9123691.
    Citations: 16     Fields:    Translation:Humans
  151. Yin Y, Hawkins KL, DeWolf WC, Morgentaler A. Heat stress causes testicular germ cell apoptosis in adult mice. J Androl. 1997 Mar-Apr; 18(2):159-65. PMID: 9154510.
    Citations: 33     Fields:    Translation:AnimalsCells
  152. Khoudary KP, Morgentaler A. Design considerations in penile prostheses: the American Medical Systems product line. J Long Term Eff Med Implants. 1997; 7(1):55-64. PMID: 10168541.
    Citations:    Fields:    Translation:Humans
  153. Morgentaler A, Bruning CO, DeWolf WC. Occult prostate cancer in men with low serum testosterone levels. JAMA. 1996 Dec 18; 276(23):1904-6. PMID: 8968017.
    Citations: 36     Fields:    Translation:Humans
  154. Socher SA, Dewolf WC, Morgentaler A. Ureteral pseudodiverticulosis: the case for the retrograde urogram. Urology. 1996 Jun; 47(6):924-7. PMID: 8677594.
    Citations: 1     Fields:    Translation:Humans
  155. Maranchie J, Morgentaler A. Management of impending sterility. Lancet. 1996 May 11; 347(9011):1344. PMID: 8622551.
    Citations:    Fields:    Translation:Humans
  156. Dahl DM, Klein D, Morgentaler A. Penile mass caused by the newly described organism Mycobacterium celatum. Urology. 1996 Feb; 47(2):266-8. PMID: 8607251.
    Citations: 5     Fields:    Translation:HumansCells
  157. Morgentaler A, Fung MY, Harris DH, Powers RD, Alper MM. Sperm morphology and in vitro fertilization outcome: a direct comparison of World Health Organization and strict criteria methodologies. Fertil Steril. 1995 Dec; 64(6):1177-82. PMID: 7589673.
    Citations: 5     Fields:    Translation:HumansCells
  158. Comiter CV, Bruning CO, Morgentaler A. Detached ciliary tufts in the epididymis: a lesson in applied anatomy. Urology. 1995 Nov; 46(5):740-2. PMID: 7495135.
    Citations:    Fields:    Translation:HumansCells
  159. Bruning CO, Morgentaler A. Re: Unilateral unitary inflatable penile prosthesis to correct impaired tumescence and severe penile deformity resulting from traumatic rupture of 1 corpus cavernosum. J Urol. 1995 Sep; 154(3):1145. PMID: 7637072.
    Citations:    Fields:    Translation:Humans
  160. Brown LF, Yeo KT, Berse B, Morgentaler A, Dvorak HF, Rosen S. Vascular permeability factor (vascular endothelial growth factor) is strongly expressed in the normal male genital tract and is present in substantial quantities in semen. J Urol. 1995 Aug; 154(2 Pt 1):576-9. PMID: 7609140.
    Citations: 4     Fields:    Translation:Humans
  161. Watson DL, Morgentaler A. Spontaneous corporeal herniation of the penis: a new abnormality of the tunica albuginea? J Urol. 1995 Mar; 153(3 Pt 1):737-40. PMID: 7861525.
    Citations:    Fields:    Translation:Humans
  162. Rubenstein SC, Green LS, Schopperle WM, DeWolf WC, Morgentaler A. Temperature-dependent expression of a 95 kD protein in rat testis. Andrologia. 1995 Mar-Apr; 27(2):107-13. PMID: 7598227.
    Citations: 1     Fields:    Translation:AnimalsCells
  163. Bruning CO, Breslin DS, Morgentaler A, Staskin DR. Experience with the penile prosthesis and artificial urinary sphincter. J Long Term Eff Med Implants. 1995; 5(1):27-45. PMID: 10163507.
    Citations:    Fields:    Translation:Humans
  164. Ho GT, Gardner H, Mostofi K, DeWolf WC, Loughlin KR, Morgentaler A. The effect of testicular nongerm cell tumors on local spermatogenesis. Fertil Steril. 1994 Jul; 62(1):162-6. PMID: 8005282.
    Citations: 1     Fields:    Translation:Humans
  165. Morgentaler A. Hyponatremic encephalopathy after endometrial ablation. JAMA. 1994 Feb 02; 271(5):344; author reply 345. PMID: 8283577.
    Citations:    Fields:    Translation:Humans
  166. Morgentaler A, DeWolf WC. A self-expanding prostatic stent for bladder outlet obstruction in high risk patients. J Urol. 1993 Nov; 150(5 Pt 2):1636-40. PMID: 7692101.
    Citations:    Fields:    Translation:Humans
  167. Morgentaler A, DeWolf WC. Vasectomy and increased risk of prostate cancer. JAMA. 1993 Aug 11; 270(6):705-6; author reply 708. PMID: 8336363.
    Citations:    Fields:    Translation:Humans
  168. Ho GT, Gardner H, DeWolf WC, Loughlin KR, Morgentaler A. Influence of testicular carcinoma on ipsilateral spermatogenesis. J Urol. 1992 Sep; 148(3):821-5. PMID: 1380990.
    Citations: 2     Fields:    Translation:Humans
  169. Kritsas JJ, Schopperle WM, DeWolf WC, Morgentaler A. Rapid high resolution two-dimensional electrophoresis of human sperm proteins. Electrophoresis. 1992 Jul; 13(7):445-9. PMID: 1425558.
    Citations:    Fields:    Translation:HumansCells
  170. Morgentaler A. Current diagnosis and management of impotence. Compr Ther. 1991 Jul; 17(7):25-30. PMID: 1742965.
    Citations:    Fields:    Translation:Humans
  171. Morgentaler A, Schopperle WM, Crocker RH, DeWolf WC. Protein differences between normal and oligospermic human sperm demonstrated by two-dimensional gel electrophoresis. Fertil Steril. 1990 Nov; 54(5):902-5. PMID: 2226924.
    Citations: 1     Fields:    Translation:HumansCells
  172. Morgentaler A, Koufman CN. Treatment of an impacted fecalith with electrohydraulic lithotripsy. N Engl J Med. 1990 Mar 22; 322(12):855-6. PMID: 2308625.
    Citations: 2     Fields:    Translation:Humans
  173. Morgentaler A, Bridge SS, Dretler SP. Management of the impacted ureteral calculus. J Urol. 1990 Feb; 143(2):263-6. PMID: 1967657.
    Citations: 20     Fields:    Translation:Humans
  174. Morgentaler A, Belville JS, Tumeh SS, Richie JP, Loughlin KR. Rational approach to evaluation and management of spontaneous perirenal hemorrhage. Surg Gynecol Obstet. 1990 Feb; 170(2):121-5. PMID: 2300864.
    Citations: 12     Fields:    Translation:Humans
  175. Belville JS, Morgentaler A, Loughlin KR, Tumeh SS. Spontaneous perinephric and subcapsular renal hemorrhage: evaluation with CT, US, and angiography. Radiology. 1989 Sep; 172(3):733-8. PMID: 2672096.
    Citations: 25     Fields:    Translation:Humans
  176. Morgentaler A, Garnick MB, Richie JP. Metastatic testicular teratoma invading the inferior vena cava. J Urol. 1988 Jul; 140(1):149-50. PMID: 3379682.
    Citations:    Fields:    Translation:HumansCells
  177. Morrell JI, Crews D, Ballin A, Morgentaler A, Pfaff DW. 3H-estradiol, 3H-testosterone and 3H-dihydrotestosterone localization in the brain of the lizard Anolis carolinensis: an autoradiographic study. J Comp Neurol. 1979 Nov 15; 188(2):201-23. PMID: 500856.
    Citations: 4     Fields:    Translation:Animals
  178. Crews D, Morgentaler A. Effects of intracranial implantation of oestradiol and dihydrotestosterone on the sexual behaviour of the lizard Anolis carolinensis. J Endocrinol. 1979 Sep; 82(3):373-81. PMID: 574532.
    Citations: 1     Fields:    Translation:HumansAnimals
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Morgentaler's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (417)
Explore
_
Co-Authors (13)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.